Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by stockman6767on Aug 14, 2014 8:52pm
404 Views
Post# 22844506

re NR and CC

re NR and CC
I think that it is pretty clear that the groundwork continues to progress, but we are a few nickels and dimes short on revenue, at least this quarter. We will see if they stand by the annual revenue projections previously made. It is also clear that the $23M gain has substantial meaning even if it is a paper profit and not cash in the register. Were there no CC tomorrow I would say it is a toss up who will control the SP tomorrow - perhaps a few pennies up or a few pennies down without much consequence for those of us who are long term holders. However there is a CC in the moorning and it will be up to PL to make believers out of those who wold sell, about all the many things begining to happening in the next several months such as the orphan drugs and 4050 trials etc etc and perhaps even convince us that we will have a backend loaded year on the revenue as well. so the ball is in PL's court. He will determine whether we trade up or down tomorrow.

Glta
Stockman
Bullboard Posts